Plant-based protein digesting enzymes such as bromelain have wide commercial value in the dietary supplements and cosmetics industries, says a report by Transparency Market Research.
Skincare product manufacturers world over have been exhibiting interest in bromelain market to expand their portfolios of products containing plant-based ingredients.
Bromelain is a protein-digesting enzyme mixture derived from the stem, fruit, and juice of the pineapple plant. It has a centuries-long history of being used to treat medical ailments, primarily throughout Central and South America.
A growing body of scientific studies have reiterated the numerous therapeutic benefits of bromelain, notably its antiedematous, anti-inflammatory, antithrombotic, and proteolytic activities. This opens the bromelain market to some of the most attractive opportunities among companies in the pharmaceutical and the dietary supplements industries. Together with the scientific basis of the therapeutic benefits, bromelain-based products are also thriving in demand on back of regulatory approvals.
The focus on clean labelling ingredients among food brands is another area of interest for players in the bromelain market. Research on using bromelain as biocatalyst is another key avenue. The various lucrative avenues will help the bromelain market to exceed valuation of US$ 1.1 Bn by 2030. During 2020 – 2030, the revenue is expected to increase at CAGR of 4.5%.
Key findings of Bromelain Market
Utilisation therapeutic properties of bromelain expand revenue potential
The healthcare industry has seen incredible opportunity in bromelain, on back of utilisation of analgesic and anti-inflammatory properties. Backed by results of in vivo and in vitro studies, the bromelain market is seeing rising R&D investments on harnessing these properties. Thus, a number of formulations using this pineapple-derived enzyme has come to the fore for treating symptoms of osteoarthritis and cardiovascular diseases such as coronary heart disease (heart attacks), cerebrovascular disease (stroke), rheumatic heart disease, and hypertension. Ongoing studies also focus also on utilising the effect of bromelain on diarrhea and blood coagulation. Another area of research is oncology.
Bromelain to see vast avenue in cosmetic sector
Players in the bromelain market are seeing vast revenue stream in the cosmetics industry. A variety of skincare products has been utilising the antimicrobial benefits of bromelain in the cosmetic sector. Recent years have seen the growing unveiling of launch of pineapple enzyme-based skincare products. Growing consumer awareness about the benefits of organic ingredients in skincare products will help open up new avenues.
Expanding chemistry of catalysts fuels rapid evolution
The rise in interest in catalyst chemistries for the production of fine chemicals and pharmaceuticals has also spurred the utilisation rate of bromelain. The bromelain market is witnessing value-grab opportunity from the widespread use of biocatalysts in various intermediate chemical processes.
Bromelain Market: Key Growth Dynamics and Avenues
- Rise in research in chronic disease management propel growth avenues in the bromelain market.
- The prevalence of cardiovascular diseases is a key trend fueling such research.
- Advent of new technologies for commercial utilisation of plant-based enzymes a key trend.
- Strides in food and beverages industry to help spur sales in the bromelain market.
- Expanding opportunities in dietary food supplements industry will also expand the horizon of stakeholders in the bromelain market.
- Top players include Bio-gen Extracts Pvt. Ltd, Xena Bio Herbals Pvt. Ltd, Challenge Bioproducts Co., Ltd, Enzybel International S.A, and Bio-gen Extracts Pvt. Ltd.
Purchase the Bromelain Market Report here: https://www.transparencymarketresearch.com/checkout.php
